Bladder tumors are the second most common genitourinary tumor after prostate tumors. In addition, it is known that urothelial carcinoma is the most common histological form. It accounts for 90% of all bladder tumors. Primary adenocarcinoma of the bladder is a rare malignant tumor. Consequently, an extension assessment is required to exclude any secondary tumor extension. Clinical presentations are not specific and remain dominated by hematuria. His prognosis is poor, and his management is essentially surgical by performing a total cystectomy associated with an extensive lymph node dissection due to radio-chemo-resistance. Background The authors report the first case of bladder adenocarcinoma. It was a 65-year-old patient who consulted at university hospital of Brazzaville for a dysuria type of slow start-up, weak jet and a total hematuria, evolving for 1 month before his consultation. The anamnesis noted a notion of smoking intoxication of a package year for 10 years. The histological diagnosis was made on basis of the results of the analysis of the trans urethral resection parts of the bladder tumor. In order to rule out any secondary extension, a radiological assessment made of computerized tomography (CT) had been carried out. The evolution was quickly fatal. Conclusion Bladder adenocarcinoma is a Clinical Anatomy Variant entity whose Its aggressive nature makes the prognosis poor, hence the interest in making the diagnosis early.
| Published in | International Journal of Clinical Urology (Volume 6, Issue 1) |
| DOI | 10.11648/j.ijcu.20220601.17 |
| Page(s) | 27-29 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Mucinous Adenocarcinoma, Bladder, Brazzaville, University Hospital
| [1] | Al-Samawi AS, Aulaqi SM. Urinary bladder cancer in Yemen. Oman Med J 2013: 28; 337-40. https://doi:10.5001/omj.2013.97. |
| [2] | Chavan S, Bray F, Lortet-Tieulent J, Goodman M and Jemal A: International variations in bladder cancer incidence and mortality. Eu Urol 2014: 66; 59-73. https://doi:10.1016/j.eururo.2016.06.010. |
| [3] | Davies Adeloye, Michael O. Harhay, Olayemi O. Ayepola, Jhonathan P. R. Dos Santos, Rotimi A. David, Olubanke O. Ogunlana et al. An estimate of the incidence of bladder cancer in Africa: a systematic review and Bayesian meta-analysis. Int J Urol. 2019: 26 (1); 102–112. doi: 10.1111/iju.13824. |
| [4] | The Global Cancer Observatory: Congo Brazzaville. https://gco.iarc.fr/today/data/factsheets/populations/178-congo-republic-of-fact-sheets.pdf (iarc.fr) vu le 11/01/2022. |
| [5] | Tyler A. Urothelial cancers: ureter, renal pelvis, and bladder. Seminars in Oncology Nursing: 2012: 28 (3): 154-162. https://doi.org/10.1016/j.soncn.2012.05.004. |
| [6] | K. Sigalas, S. I. Tyritzis, E. Trigka, I. Katafigiotis, N. Kavantzas, and K. G. Stravodimos, “A male presenting with a primary mucinous bladder carcinoma: a case report,” Cases Journal: 2010: 3 (2): 49. https://doi.org/10.1186/1757-1626-3-49. |
| [7] | Baffigo G, Delicato G, Bianchi D, Signore S, Tartaglia E, Corvese F et al. Mucinous adenocarcinoma of the urinary bladder. Am J Case Rep, 2012; 13: 99-101. https://doi:10.12659/AJCR.882998. |
| [8] | Odzébé AWS, Bouya PA, NKoua Mbon JB et Ekat MH. Les tumeurs de vessie: aspects épidémiologiques et thérapeutiques à Brazzaville. J Afr Cancer: 2011: 3: 36–39. |
| [9] | Dow JA, Young JD: Mesonephric adenocarcinoma of the bladder. J Urol. 1968, 100 (4): 466-9. https://doi:10.1016/s0022-5347(17)62554-0. |
| [10] | Fabrizio Di Maida, Giuliano Amorim Aita, and Daniele Amorim Aita. Case Report Primary Mucinous Adenocarcinoma of Urinary Bladder with Signet-Ring Cells: Description of an Uncommon Case and Critical Points in Its Management. Hindawi Publishing Corporation. Case Reports in Urology: 2016, Article ID 6080859, 3 pages. https://doi:10.1155/2016/6080859. |
| [11] | Zhang BY, Aguilar J, Yang M, Wang P, Li B. Mucinous metaplasia in urothelial tract may be the precancerous lesion of mucinous adenocarcinoma: report of two cases and review of literature. Int J Clin Exp Med 2014: 7 (1); 285-289. https://doi.org/10.3892/mco.2016.985. |
| [12] | Taylor S, Bacchini P, Bertoni F: An isolated vertebral metastasis of ura chal adenocarcinoma. Arch Pathol Lab Med, 2004: 128 (9); 1043–45. https://doi:10.5858/2004-128-1043-AIVMOU. |
| [13] | Oliva E., Amin M. B., Jimenez R., Young R. H.: Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am. J. Surg. Pathol 2002: 26; 190-197. https://doi:10.1097/00000478-200202000-00005. |
| [14] | Pan X, Jin L, He T, Hu J, Quan J, Zhou L et al. Mucinous adenocarcinoma of the bladder: A case report and review of the literature. Molecular and clinical oncology 2016: 5; 447-448. https://doi.org/10.3892/mco.2016.985. |
| [15] | Zaghloul MS, Nouh A, Nazmy M, Ramzy S, Zaghloul AS, Sedira MA et al: Long-term results of primary adeno- carcinoma of the urinary bladder: A report on 192 patients. Urol Oncol 2006: 24; 13-20. https://doi.org/10.1016/j.urolonc.2005.05.027. |
| [16] | Larre S, Leon P, El Bakri A. cancer de la vessie: diagnostic et principes de traitement. EMC-Urologie: 2016: 9 (3): 1-17. |
| [17] | Martí JL, Queipo Zaragozá JA, Bonillo García MA et al: Mucinous adenocarcinoma of the bladder. Actas Urol Esp, 2003; 27 (4): 274–80. https://doi:10.12659/AJCR.882998. |
APA Style
Ondziel-Opara Steve Aristide, Ondongo Atipo Armel Melvin, Mouamba Fabien Gael, Mouss Banga Roland Bertille, Dimi Nyanga Yannick Isjody, et al. (2022). First Congolese Case Report of Mucinous Adenocarcinoma of the Bladder at Brazzaville University Hospital. International Journal of Clinical Urology, 6(1), 27-29. https://doi.org/10.11648/j.ijcu.20220601.17
ACS Style
Ondziel-Opara Steve Aristide; Ondongo Atipo Armel Melvin; Mouamba Fabien Gael; Mouss Banga Roland Bertille; Dimi Nyanga Yannick Isjody, et al. First Congolese Case Report of Mucinous Adenocarcinoma of the Bladder at Brazzaville University Hospital. Int. J. Clin. Urol. 2022, 6(1), 27-29. doi: 10.11648/j.ijcu.20220601.17
AMA Style
Ondziel-Opara Steve Aristide, Ondongo Atipo Armel Melvin, Mouamba Fabien Gael, Mouss Banga Roland Bertille, Dimi Nyanga Yannick Isjody, et al. First Congolese Case Report of Mucinous Adenocarcinoma of the Bladder at Brazzaville University Hospital. Int J Clin Urol. 2022;6(1):27-29. doi: 10.11648/j.ijcu.20220601.17
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcu.20220601.17,
author = {Ondziel-Opara Steve Aristide and Ondongo Atipo Armel Melvin and Mouamba Fabien Gael and Mouss Banga Roland Bertille and Dimi Nyanga Yannick Isjody and Odzébé Anani Wencesl Severin and Bouya Prosper Alain},
title = {First Congolese Case Report of Mucinous Adenocarcinoma of the Bladder at Brazzaville University Hospital},
journal = {International Journal of Clinical Urology},
volume = {6},
number = {1},
pages = {27-29},
doi = {10.11648/j.ijcu.20220601.17},
url = {https://doi.org/10.11648/j.ijcu.20220601.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220601.17},
abstract = {Bladder tumors are the second most common genitourinary tumor after prostate tumors. In addition, it is known that urothelial carcinoma is the most common histological form. It accounts for 90% of all bladder tumors. Primary adenocarcinoma of the bladder is a rare malignant tumor. Consequently, an extension assessment is required to exclude any secondary tumor extension. Clinical presentations are not specific and remain dominated by hematuria. His prognosis is poor, and his management is essentially surgical by performing a total cystectomy associated with an extensive lymph node dissection due to radio-chemo-resistance. Background The authors report the first case of bladder adenocarcinoma. It was a 65-year-old patient who consulted at university hospital of Brazzaville for a dysuria type of slow start-up, weak jet and a total hematuria, evolving for 1 month before his consultation. The anamnesis noted a notion of smoking intoxication of a package year for 10 years. The histological diagnosis was made on basis of the results of the analysis of the trans urethral resection parts of the bladder tumor. In order to rule out any secondary extension, a radiological assessment made of computerized tomography (CT) had been carried out. The evolution was quickly fatal. Conclusion Bladder adenocarcinoma is a Clinical Anatomy Variant entity whose Its aggressive nature makes the prognosis poor, hence the interest in making the diagnosis early.},
year = {2022}
}
TY - JOUR T1 - First Congolese Case Report of Mucinous Adenocarcinoma of the Bladder at Brazzaville University Hospital AU - Ondziel-Opara Steve Aristide AU - Ondongo Atipo Armel Melvin AU - Mouamba Fabien Gael AU - Mouss Banga Roland Bertille AU - Dimi Nyanga Yannick Isjody AU - Odzébé Anani Wencesl Severin AU - Bouya Prosper Alain Y1 - 2022/02/16 PY - 2022 N1 - https://doi.org/10.11648/j.ijcu.20220601.17 DO - 10.11648/j.ijcu.20220601.17 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 27 EP - 29 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20220601.17 AB - Bladder tumors are the second most common genitourinary tumor after prostate tumors. In addition, it is known that urothelial carcinoma is the most common histological form. It accounts for 90% of all bladder tumors. Primary adenocarcinoma of the bladder is a rare malignant tumor. Consequently, an extension assessment is required to exclude any secondary tumor extension. Clinical presentations are not specific and remain dominated by hematuria. His prognosis is poor, and his management is essentially surgical by performing a total cystectomy associated with an extensive lymph node dissection due to radio-chemo-resistance. Background The authors report the first case of bladder adenocarcinoma. It was a 65-year-old patient who consulted at university hospital of Brazzaville for a dysuria type of slow start-up, weak jet and a total hematuria, evolving for 1 month before his consultation. The anamnesis noted a notion of smoking intoxication of a package year for 10 years. The histological diagnosis was made on basis of the results of the analysis of the trans urethral resection parts of the bladder tumor. In order to rule out any secondary extension, a radiological assessment made of computerized tomography (CT) had been carried out. The evolution was quickly fatal. Conclusion Bladder adenocarcinoma is a Clinical Anatomy Variant entity whose Its aggressive nature makes the prognosis poor, hence the interest in making the diagnosis early. VL - 6 IS - 1 ER -
Information
Email: